Unknown

Dataset Information

0

Application of strain-promoted azide-alkyne cycloaddition and tetrazine ligation to targeted Fc-drug conjugates.


ABSTRACT: We have previously described an approach whereby antibody Fc fragments harboring a single C-terminal selenocysteine residue (Fc-Sec) are directed against a variety of targets by changing the peptide or small molecule to which they are conjugated. In the present work, we describe methodology for improving the efficacy of these Fc-Sec conjugates by incorporating cytotoxic drugs. The Fc-Sec protein is first programmed to target specific tumor cell types by attachment of a bifunctional linker that contains a "clickable" handle (e.g., cyclobutane or cyclooctyne) in addition to a tumor cell-binding peptide or small molecule. Following Fc-Sec conjugation, a cytotoxic warhead is then attached by cycloaddition reactions of tetrazine or azide-containing linker. To validate this approach, we used a model system in which folic acid (FA) is the targeting moiety and a disulfide-linked biotin moiety serves as a cytotoxic drug surrogate. We demonstrated successful targeting of Fc-Sec proteins to folate-receptor expressing tumor cells. Tetrazine ligation was found to be an efficient method for biotin "arming" of the folate-targeted Fc-Sec proteins. We also report novel bioconjugation methodologies that use [4 + 2] cycloaddition reactions between tetrazines and cyclooctynes.

SUBMITTER: Thomas JD 

PROVIDER: S-EPMC3474869 | biostudies-literature | 2012 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Application of strain-promoted azide-alkyne cycloaddition and tetrazine ligation to targeted Fc-drug conjugates.

Thomas Joshua D JD   Cui Huiting H   North Patrick J PJ   Hofer Thomas T   Rader Christoph C   Burke Terrence R TR  

Bioconjugate chemistry 20120925 10


We have previously described an approach whereby antibody Fc fragments harboring a single C-terminal selenocysteine residue (Fc-Sec) are directed against a variety of targets by changing the peptide or small molecule to which they are conjugated. In the present work, we describe methodology for improving the efficacy of these Fc-Sec conjugates by incorporating cytotoxic drugs. The Fc-Sec protein is first programmed to target specific tumor cell types by attachment of a bifunctional linker that c  ...[more]

Similar Datasets

| S-EPMC5990007 | biostudies-literature
| S-EPMC5967854 | biostudies-literature
| S-EPMC8163418 | biostudies-literature
| S-EPMC3996923 | biostudies-literature
| S-EPMC3069858 | biostudies-literature
| S-EPMC3306817 | biostudies-literature
| S-EPMC5999037 | biostudies-literature
| S-EPMC5991799 | biostudies-literature
| S-EPMC4128391 | biostudies-literature
| S-EPMC8778659 | biostudies-literature